Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

Phathom Pharmaceuticals (PHAT) Shares Issued (2022 - 2025)

Phathom Pharmaceuticals (PHAT) has disclosed Shares Issued for 4 consecutive years, with $543.3 million as the latest value for Q4 2025.

  • Quarterly Shares Issued changed 0.0% to $543.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $543.7 million through Dec 2025, down 63.95% year-over-year, with the annual reading at $1.6 million for FY2025, 2.44% up from the prior year.
  • Shares Issued for Q4 2025 was $543.3 million at Phathom Pharmaceuticals, up from $293000.0 in the prior quarter.
  • The five-year high for Shares Issued was $543.3 million in Q3 2024, with the low at -$543.2 million in Q2 2025.
  • Average Shares Issued over 4 years is $183.9 million, with a median of $38.7 million recorded in 2023.
  • The sharpest move saw Shares Issued surged 1303.88% in 2024, then crashed 228.88% in 2025.
  • Over 4 years, Shares Issued stood at $24.6 million in 2022, then skyrocketed by 57.32% to $38.7 million in 2023, then soared by 1303.88% to $543.3 million in 2024, then changed by 0.0% to $543.3 million in 2025.
  • According to Business Quant data, Shares Issued over the past three periods came in at $543.3 million, $293000.0, and -$543.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.